The effects of two anticonvulsants, phenytoin (PHT) and valproate (VPA), on the vitamin D
3-activating enzyme (cytochrome P-450
D25) have been studied. PHT was found to inhibit the activities of cytochrome P-450
D25 in Wistar rat liver microsomes and mito chondria, but VPA was found not to inhibit them, even over a wide concentration range. Two months-administration with PHT a competitive inhibitor of the microsomal cyto-chrome P-450
D25, was found to inducethe microsomal cytochrome P-450
D25 and to reduce the activity of the mitochondrial cytochrome P-450
D25 in liver of male Wistar rats. The administration with VPA was found neither to reduce the activity of the mitochondrial cytochrome P-450
D25, nor to induce the microsomal cytochrome P-450
D25. It is possible that the inhibition of the liver cytochrome P-450
D25 activity by PHT may cause the reduction of vitamin D
3-bioactivation and may result in the disability of Ca-metabolism and osteoporosis, in the long-term clinical administration.
View full abstract